$ANEB
Anebulo Pharmaceuticals, Inc.
Nasdaq · Pharmaceutical Preparations · Lakeway, TX
ANEB chart
What traders are saying about $ANEB
Latest postsAnebulo Pharmaceuticals, Inc. news
Anebulo Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$8.5M | -$8.2M | -$11.7M | -$6.8M |
| Diluted EPS | $-0.25 | $-0.32 | $-0.47 | $0.29 |
| Total assets (year end) | $9.4M | $15.8M | $7.5M | $16.9M |
| Cash and equivalents (year end) | $9.0M | $15.0M | $6.6M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Anebulo Pharmaceuticals, Inc.
- Ticker
- ANEB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Lakeway, TX
- Incorporated in
- DE
- Fiscal year end
- June 30
- SEC CIK
- 1815974
Frequently asked questions
What exchange is Anebulo Pharmaceuticals, Inc. listed on?
Anebulo Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ANEB.
What industry is Anebulo Pharmaceuticals, Inc. in?
Anebulo Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations".
Where is Anebulo Pharmaceuticals, Inc. headquartered?
Anebulo Pharmaceuticals, Inc.'s business address on file with the SEC is in Lakeway, TX.
When does Anebulo Pharmaceuticals, Inc.'s fiscal year end?
Anebulo Pharmaceuticals, Inc.'s fiscal year ends on June 30.